PHARMASEAL and Mayet Announce Strategic Integration Partnership
07.08.2025 - 18:07:44 | prnewswire.co.ukAbout PHARMASEAL
PHARMASEAL International Ltd, established in 2016, was founded with a vision to create a unified trial management platform that supports global life science organizations in managing clinical trials aimed at improving human health. The company's team of clinical technology experts designed and developed the Engility® Trial Management platform to alleviate the burdens of clinical operations, enhance collaboration and oversight, and provide a unified suite that boosts clinical operations productivity. The Engility platform is engineered on a modern cloud architecture and designed to scale efficiently for all types of trials. pharmaseal.co
About Mayet
Mayet is a vendor management company that optimizes clinical trial operations by streamlining compliance tracking, reducing administrative burden, and improving collaboration between research stakeholders and service providers. Its adaptive technology supports continuous process improvement, providing sponsors, CROs, and research sites with actionable insights for data-driven outsourcing in clinical research. For more details visit Mayetrx.com
View original content:https://www.prnewswire.co.uk/news-releases/pharmaseal-and-mayet-announce-strategic-integration-partnership-302424432.html
So schätzen die Börsenprofis Aktien ein!
Für. Immer. Kostenlos.
